• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number JHJR050502J
Device Problem Obstruction of Flow (2423)
Patient Problem Occlusion (1984)
Event Date 01/15/2019
Event Type  Injury  
Manufacturer Narrative
Please note: an additional gore® viabahn® endoprosthesis (jhjr052502j/18397400) has been included in this report, as it is unknown which gore® viabahn® device may have contributed to this event.(b)(4).Per the gore® viabahn® endoprosthesis instructions for use, complications associated with the use of the gore® viabahn® endoprosthesis may include, but are not limited to thrombosis or occlusion.
 
Event Description
On (b)(6) 2018, the patient was implanted with two gore® viabahn® endoprostheses with heparin bioactive surface (jhjr050502j/16466569 and jhjr052502j/18397400) to treat an occlusion of the right superficial femoral artery.On an unknown date in (b)(6) 2019, follow-up examination reportedly revealed occlusion in one gore® viabahn® device (it is unknown which device was occluded).There was reported collateral circulation approximately 7cm distal to the originally implanted stent graft.It was reported that the collateral circulation resulted in a competing blood flow, causing the occlusion.On (b)(6) 2019, the patient underwent endovascular treatment using an additional gore® viabahn® endoprosthesis with heparin bioactive surface and thrombectomy to treat the occlusion.The additional stent graft was placed to cover the collateral circulation.The patient tolerated the procedure.
 
Manufacturer Narrative
Please note correction to section g5.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8327816
MDR Text Key135864510
Report Number2017233-2019-00075
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 02/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/02/2020
Device Catalogue NumberJHJR050502J
Device Lot Number16466569
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age70 YR
-
-